Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
gut microbiota1104 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A09323 | 31790895 | Phytomedicine | Amelioration of non-alcoholic steatohepatitis by Qushi Huayu decoction is associated with inhibition of the intestinal mitogen-activated protein kinase pathway. | 2019 | Details |
| A09338 | 31786271 | Physiol Behav | Modulation of hippocampal TLR4/BDNF signal pathway using probiotics is a step closer towards treating cognitive impairment in NASH model. | 2019 | Details |
| A09358 | 31779730 | Br J Nutr | Dietary protein insufficiency: an important consideration in fatty liver disease? | 2019 | Details |
| A09361 | 31777896 | Food Funct | Attenuation of metabolic syndrome in the ob/ob mouse model by resistant starch intervention is dose dependent. | 2019 | Details |
| A09373 | 31771682 | Br J Nutr | Crude extract of Camellia oleifera pomace ameliorates the progression of non-alcoholic fatty liver disease via decreasing fat accumulation, insulin resistance and inflammation. | 2019 | Details |
| A09418 | 31757631 | Nutr Res | Steatosis and gut microbiota dysbiosis induced by high-fat diet are reversed by 1-week chow diet administration. | 2019 | Details |
| A09432 | 31752378 | Nutrients | Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter? | 2019 | Details |
| A09443 | 31746883 | Food Funct | Artemisia sphaerocephala Krasch polysaccharide prevents hepatic steatosis in high fructose-fed mice associated with changes in the gut microbiota. | 2019 | Details |
| A09447 | 31745030 | Indian J Med Microbiol | Gut microbiota and its mysteries. | 2020 | Details |
| A09481 | 31727922 | Sci Rep | Fecal microbiome signatures of pancreatic cancer patients. | 2019 | Details |
| A09485 | 31726747 | Diseases | Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far? | 2019 | Details |
| A09493 | 31723265 | Nature | Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease. | 2019 | Details |
| A09527 | 31707624 | Rev Endocr Metab Disord | Dietary lipids, gut microbiota and lipid metabolism. | 2019 | Details |
| A09575 | 31689910 | Nutrients | The Role of Probiotics in Nonalcoholic Fatty Liver Disease: A New Insight into Therapeutic Strategies. | 2019 | Details |
| A09644 | 31661720 | Hepatol Res | Changes of gut microbiota during silybin-mediated treatment of high-fat diet-induced non-alcoholic fatty liver disease in mice. | 2020 | Details |
| A09666 | 31653116 | Int J Mol Sci | The Positive Effects of Grifola frondosa Heteropolysaccharide on NAFLD and Regulation of the Gut Microbiota. | 2019 | Details |
| A09693 | 31645659 | Acta Pharmacol Sin | WZ66, a novel acetyl-CoA carboxylase inhibitor, alleviates nonalcoholic steatohepatitis (NASH) in mice. | 2019 | Details |
| A09757 | 31622696 | J Hepatol | The gut-liver axis in liver disease: Pathophysiological basis for therapy. | 2019 | Details |
| A09811 | 31601229 | Trials | Effect of probiotic supplementation in nonalcoholic steatohepatitis patients: PROBILIVER TRIAL protocol. | 2019 | Details |
| A09818 | 31599067 | Mol Nutr Food Res | Mastiha (Pistacia lentiscus) Improves Gut Microbiota Diversity, Hepatic Steatosis, and Disease Activity in a Biopsy-Confirmed Mouse Model of Advanced Non-Alcoholic Steatohepatitis and Fibrosis. | 2019 | Details |
| A09891 | 31573042 | Int J Mol Med | Fatty liver and alteration of the gut microbiome induced by diallyl disulfide. | 2019 | Details |
| A09932 | 31555219 | Front Endocrinol (Lausanne) | Gut Dysfunction and Non-alcoholic Fatty Liver Disease. | 2019 | Details |
| A09949 | 31547555 | Nutrients | Regulation of Gut Microbiota and Metabolic Endotoxemia with Dietary Factors. | 2019 | Details |
| A09957 | 31543676 | World J Gastroenterol | Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation. | 2019 | Details |
| A09960 | 31543403 | Cell Metab | Fatty Liver Disease Caused by High-Alcohol-Producing Klebsiella pneumoniae. | 2019 | Details |
| A09973 | 31539420 | PLoS One | Neurobehavioral dysfunction in non-alcoholic steatohepatitis is associated with hyperammonemia, gut dysbiosis, and metabolic and functional brain regional deficits. | 2019 | Details |
| A10006 | 31528245 | World J Hepatol | Prolonged high-fat-diet feeding promotes non-alcoholic fatty liver disease and alters gut microbiota in mice. | 2019 | Details |
| A10039 | 31517324 | J Gastrointestin Liver Dis | Effects of Dietary Intervention on Gut Microbiota and Metabolic-Nutritional Profile of Outpatients with Non-Alcoholic Steatohepatitis: a Randomized Clinical Trial. | 2019 | Details |
| A10045 | 31515740 | Hepatol Int | Significant decrease in Faecalibacterium among gut microbiota in nonalcoholic fatty liver disease: a large BMI- and sex-matched population study. | 2019 | Details |
| A10058 | 31506421 | Exp Mol Med | Indole-3-propionic acid inhibits gut dysbiosis and endotoxin leakage to attenuate steatohepatitis in rats. | 2019 | Details |
| A10060 | 31505802 | Nutrients | Relationship between Changes in Microbiota and Liver Steatosis Induced by High-Fat Feeding-A Review of Rodent Models. | 2019 | Details |
| A10092 | 31491513 | Int J Biol Macromol | MDG-1, an Ophiopogon polysaccharide, restrains process of non-alcoholic fatty liver disease via modulating the gut-liver axis. | 2019 | Details |
| A10099 | 31484323 | Nutrients | Indole-3-Acetic Acid Alleviates Nonalcoholic Fatty Liver Disease in Mice via Attenuation of Hepatic Lipogenesis, and Oxidative and Inflammatory Stress. | 2019 | Details |
| A10144 | 31470288 | Nutr Res | Gnotobiotic mice inoculated with Firmicutes, but not Bacteroidetes, deteriorate nonalcoholic fatty liver disease severity by modulating hepatic lipid metabolism. | 2019 | Details |
| A10189 | 31442319 | Hepatology | Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation. | 2020 | Details |
| A10218 | 31426291 | Int J Mol Sci | Antioxidant Versus Pro-Apoptotic Effects of Mushroom-Enriched Diets on Mitochondria in Liver Disease. | 2019 | Details |
| A10220 | 31425956 | Diabetes Metab Syndr | A review of synbiotic efficacy in non-alcoholic fatty liver disease as a therapeutic approach. | 2019 | Details |
| A10252 | 31410156 | Exp Ther Med | Role and effective therapeutic target of gut microbiota in NAFLD/NASH. | 2019 | Details |
| A10323 | 31388096 | Int J Obes (Lond) | Circulating microbiota-derived metabolites: a "liquid biopsy? | 2019 | Details |
| A10330 | 31387054 | Phytomedicine | The combination of Ilexhainanoside D and ilexsaponin A1 reduces liver inflammation and improves intestinal barrier function in mice with high-fat diet-induced non-alcoholic fatty liver disease. | 2019 | Details |
| A10338 | 31384531 | Acta Pharm Sin B | Ablation of gut microbiota alleviates obesity-induced hepatic steatosis and glucose intolerance by modulating bile acid metabolism in hamsters. | 2019 | Details |
| A10339 | 31384519 | Biosci Microbiota Food Health | The role of gut microbiota in non-alcoholic fatty liver disease: pathways of mechanisms. | 2019 | Details |
| A10351 | 31379412 | J Clin Biochem Nutr | Green tea polyphenol (epigallocatechin-3-gallate) improves gut dysbiosis and serum bile acids dysregulation in high-fat diet-fed mice. | 2019 | Details |
| A10364 | 31373710 | Aliment Pharmacol Ther | Review article: can bugs be drugs? The potential of probiotics and prebiotics as treatment for non-alcoholic fatty liver disease. | 2019 | Details |
| A10373 | 31367159 | World J Gastroenterol | Lingguizhugan decoction attenuates diet-induced obesity and hepatosteatosis via gut microbiota. | 2019 | Details |
| A10407 | 31349604 | Nutrients | Gut Microbiota-Derived Components and Metabolites in the Progression of Non-Alcoholic Fatty Liver Disease (NAFLD). | 2019 | Details |
| A10416 | 31344854 | J Clin Med | Gut Microbiota and Risk of Persistent Nonalcoholic Fatty Liver Diseases. | 2019 | Details |
| A10423 | 31342533 | Aliment Pharmacol Ther | Improvement of non-invasive markers of NAFLD from an individualised, web-based exercise program. | 2019 | Details |
| A10427 | 31341422 | Mediators Inflamm | Role of Bile Acids in Dysbiosis and Treatment of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10451 | 31332389 | Nat Med | Healthspan and lifespan extension by fecal microbiota transplantation into progeroid mice. | 2019 | Details |
| A10473 | 31322321 | Mol Nutr Food Res | A Network Involving Gut Microbiota, Circulating Bile Acids, and Hepatic Metabolism Genes That Protects Against Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
| A10510 | 31308634 | Drug Des Devel Ther | The protective effect and mechanism of the FXR agonist obeticholic acid via targeting gut microbiota in non-alcoholic fatty liver disease. | 2019 | Details |
| A10580 | 31281460 | Exp Ther Med | Aged garlic extract ameliorates fatty liver and insulin resistance and improves the gut microbiota profile in a mouse model of insulin resistance. | 2019 | Details |
| A10611 | 31272028 | J Nutr Biochem | 1-Deoxynojirimycin improves high fat diet-induced nonalcoholic steatohepatitis by restoring gut dysbiosis. | 2019 | Details |
| A10614 | 31271251 | Mol Nutr Food Res | Diet Consisting of Balanced Yogurt, Fruit, and Vegetables Modifies the Gut Microbiota and Protects Mice against Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10619 | 31269758 | Mar Drugs | Chitosan Oligosaccharide Ameliorates Nonalcoholic Fatty Liver Disease (NAFLD) in Diet-Induced Obese Mice. | 2019 | Details |
| A10620 | 31269076 | PLoS One | Microbial and metabolomic remodeling by a formula of Sichuan dark tea improves hyperlipidemia in apoE-deficient mice. | 2019 | Details |
| A10629 | 31263097 | Nat Commun | Author Correction: The gut microbiota in infants of obese mothers increases inflammation and susceptibility to NAFLD. | 2019 | Details |
| A10731 | 31219051 | JMIR Res Protoc | Diet-Induced Alteration of Microbiota and Development of Obesity, Nonalcoholic Fatty Liver Disease, and Diabetes: Study Protocol of a Prospective Study. | 2019 | Details |
| A10756 | 31208147 | Nutrients | Glycine Metabolism and Its Alterations in Obesity and Metabolic Diseases. | 2019 | Details |
| A10757 | 31208043 | Nutrients | Dietary Fiber in Bilberry Ameliorates Pre-Obesity Events in Rats by Regulating Lipid Depot, Cecal Short-Chain Fatty Acid Formation and Microbiota Composition. | 2019 | Details |
| A10767 | 31203627 | J Agric Food Chem | Polyphenol-Rich Loquat Fruit Extract Prevents Fructose-Induced Nonalcoholic Fatty Liver Disease by Modulating Glycometabolism, Lipometabolism, Oxidative Stress, Inflammation, Intestinal Barrier, and Gut Microbiota in Mice. | 2019 | Details |
| A10795 | 31189495 | Clin Nutr | Resveratrol attenuates high-fat diet-induced non-alcoholic steatohepatitis by maintaining gut barrier integrity and inhibiting gut inflammation through regulation of the endocannabinoid system. | 2019 | Details |
| A10800 | 31185686 | Nutrients | A New Light on Vitamin D in Obesity: A Novel Association with Trimethylamine-N-Oxide (TMAO). | 2019 | Details |
| A10802 | 31185249 | Cancer Lett | New insights and therapeutic implication of gut microbiota in non-alcoholic fatty liver disease and its associated liver cancer. | 2019 | Details |
| A10810 | 31177662 | Zhonghua Gan Zang Bing Za Zhi | [Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease]. | 2019 | Details |
| A10826 | 31171889 | World J Gastroenterol | Trimethylamine N-oxide attenuates high-fat high-cholesterol diet-induced steatohepatitis by reducing hepatic cholesterol overload in rats. | 2019 | Details |
| A10827 | 31170503 | Biochim Biophys Acta Mol Cell Biol Lipids | Turnover of bile acids in liver, serum and caecal content by high-fat diet feeding affects hepatic steatosis in rats. | 2019 | Details |
| A10835 | 31165837 | Food Funct | Sinapine reduces non-alcoholic fatty liver disease in mice by modulating the composition of the gut microbiota. | 2019 | Details |
| A10860 | 31152791 | Free Radic Biol Med | Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease. | 2019 | Details |
| A10868 | 31149745 | Aliment Pharmacol Ther | Review article: emerging role of the gut microbiome in the progression of nonalcoholic fatty liver disease and potential therapeutic implications. | 2019 | Details |
| A10894 | 31136662 | Am J Clin Nutr | Yogurt improves insulin resistance and liver fat in obese women with nonalcoholic fatty liver disease and metabolic syndrome: a randomized controlled trial. | 2019 | Details |
| A10975 | 31095863 | Mol Nutr Food Res | Trimethylamine N-Oxide Aggravates Liver Steatosis through Modulation of Bile Acid Metabolism and Inhibition of Farnesoid X Receptor Signaling in Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10986 | 31090267 | J Zhejiang Univ Sci B | Bile-ology: from bench to bedside. | 2019 | Details |
| A11110 | 31037218 | J Nutr Sci | Coffee prevents fatty liver disease induced by a high-fat diet by modulating pathways of the gut-liver axis. | 2019 | Details |
| A11172 | 31011312 | Case Rep Gastroenterol | Gut Microbiota Profiles in Nonalcoholic Fatty Liver Disease and Its Possible Impact on Disease Progression Evaluated with Transient Elastography: Lesson Learnt from 60 Cases. | 2019 | Details |
| A11177 | 31010049 | Int J Mol Sci | Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview. | 2019 | Details |
| A11181 | 31009401 | Eur J Gastroenterol Hepatol | The promising role of probiotic and synbiotic therapy in aminotransferase levels and inflammatory markers in patients with nonalcoholic fatty liver disease - a systematic review and meta-analysis. | 2019 | Details |
| A11187 | 31007175 | Biochim Biophys Acta Mol Basis Dis | Outside the liver box: The gut microbiota as pivotal modulator of liver diseases. | 2018 | Details |
| A11217 | 30991877 | Gut Microbes | High intake of dietary fructose in overweight/obese teenagers associated with depletion of Eubacterium and Streptococcus in gut microbiome. | 2019 | Details |
| A11259 | 30971408 | Dis Model Mech | Beneficial effects of exercise on gut microbiota functionality and barrier integrity, and gut-liver crosstalk in an in vivo model of early obesity and non-alcoholic fatty liver disease. | 2019 | Details |
| A11311 | 30944821 | J Clin Transl Hepatol | Fatty Liver Disease and Gut Microbiota: A Comprehensive Update. | 2018 | Details |
| A11322 | 30938723 | Food Funct | Spinach consumption ameliorates the gut microbiota and dislipaemia in rats with diet-induced non-alcoholic fatty liver disease (NAFLD). | 2019 | Details |
| A11394 | 30915401 | Clin Exp Hepatol | Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease. | 2019 | Details |
| A11483 | 30877020 | Pharmacol Ther | Intestinal microbiome as a novel therapeutic target for local and systemic inflammation. | 2019 | Details |
| A11500 | 30870486 | PLoS One | Fecal and blood microbiota profiles and presence of nonalcoholic fatty liver disease in obese versus lean subjects. | 2019 | Details |
| A11522 | 30860877 | Am J Physiol Endocrinol Metab | Human Paneth cell α-defensin-5 treatment reverses dyslipidemia and improves glucoregulatory capacity in diet-induced obese mice. | 2019 | Details |
| A11527 | 30856537 | Biomed Pharmacother | Ferulic acid ameliorates nonalcoholic fatty liver disease and modulates the gut microbiota composition in high-fat diet fed ApoE-/- mice. | 2019 | Details |
| A11574 | 30833801 | World J Gastroenterol | Procyanidin B2 protects against diet-induced obesity and non-alcoholic fatty liver disease via the modulation of the gut microbiota in rabbits. | 2019 | Details |
| A11579 | 30832423 | Microorganisms | Microbial Population Changes and Their Relationship with Human Health and Disease. | 2019 | Details |
| A11618 | 30818779 | Nutrients | Green Coffee Extract Improves Cardiometabolic Parameters and Modulates Gut Microbiota in High-Fat-Diet-Fed ApoE-/- Mice. | 2019 | Details |
| A11629 | 32461811 | Liver Res | The role of gut microbiota in liver disease development and treatment. | 2019 | Details |
| A11634 | 30810328 | Rev Esp Enferm Dig | An altered fecal microbiota profile in patients with non-alcoholic fatty liver disease (NAFLD) associated with obesity. | 2019 | Details |
| A11663 | 30798598 | J Agric Food Chem | Intestinal Barrier Function-Non-alcoholic Fatty Liver Disease Interactions and Possible Role of Gut Microbiota. | 2019 | Details |
| A11666 | 30797009 | Int J Biol Macromol | Mussel polysaccharide α-D-glucan (MP-A) protects against non-alcoholic fatty liver disease via maintaining the homeostasis of gut microbiota and regulating related gut-liver axis signaling pathways. | 2019 | Details |
| A11686 | 30791767 | Expert Rev Gastroenterol Hepatol | Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease. | 2019 | Details |
| A11761 | 30762938 | Mol Nutr Food Res | Jamun (Eugenia jambolana Lam.) Fruit Extract Prevents Obesity by Modulating the Gut Microbiome in High-Fat-Diet-Fed Mice. | 2019 | Details |
| A11798 | 30736329 | Nutrients | Impact of SchisandraChinensis Bee Pollen on Nonalcoholic Fatty Liver Disease and Gut Microbiota in HighFat Diet Induced Obese Mice. | 2019 | Details |
| A11821 | 30720827 | Food Funct | Monascus yellow, red and orange pigments from red yeast rice ameliorate lipid metabolic disorders and gut microbiota dysbiosis in Wistar rats fed on a high-fat diet. | 2019 | Details |
| A11822 | 30720188 | Eur Rev Med Pharmacol Sci | Intestinal permeability in physiological and pathological conditions: major determinants and assessment modalities. | 2019 | Details |